MICHAEL HOLLIDAY to Humans
This is a "connection" page, showing publications MICHAEL HOLLIDAY has written about Humans.
Connection Strength
0.102
-
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336.
Score: 0.022
-
Chronic Interstitial Nephritis in Agricultural Communities: Observational and Mechanistic Evidence Supporting the Role of Nephrotoxic Agrochemicals. Clin J Am Soc Nephrol. 2024 Apr 01; 19(4):538-545.
Score: 0.022
-
Editorial: Advancements in the management of kidney disease and electrolyte derangements. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):395-398.
Score: 0.020
-
C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines. PLoS One. 2013; 8(9):e74768.
Score: 0.011
-
Nanoscale Direct-to-Biology Optimization of Cdk2 Inhibitors. J Med Chem. 2026 Apr 23; 69(8):9142-9162.
Score: 0.007
-
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Ka Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discov. 2024 Feb 08; 14(2):240-257.
Score: 0.006
-
Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231200386.
Score: 0.005
-
Interactions between leucines within the signal peptides of megalin and stanniocalcin-1 are crucial for regulation of mitochondrial metabolism. Lab Invest. 2022 05; 102(5):534-544.
Score: 0.005
-
Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.
Score: 0.004